{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:02:02Z","timestamp":1784505722384,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Scientific Research Foundation of Shanghai fourth people\u2019s hospital affiliated Tongji university","award":["No. SY-XKZT-2025-1019"],"award-info":[{"award-number":["No. SY-XKZT-2025-1019"]}]},{"name":"Scientific Research Foundation of Shanghai fourth people\u2019s hospital affiliated Tongji university","award":["No. sykygd13101"],"award-info":[{"award-number":["No. sykygd13101"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-06004-3","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T09:34:04Z","timestamp":1779528844000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Drug-induced psoriasis following sacubitril\/valsartan: a case report and literature review"],"prefix":"10.1186","volume":"26","author":[{"given":"Tang","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefen","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"issue":"9","key":"6004_CR1","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.repc.2016.11.013","volume":"36","author":"P Marques da Silva","year":"2017","unstructured":"Marques da Silva P, Aguiar C. Sacubitril\/valsartan: An important piece in the therapeutic puzzle of heart failure. Rev Port Cardiol. 2017;36(9):655\u201368.","journal-title":"Rev Port Cardiol"},{"issue":"5","key":"6004_CR2","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cardfail.2022.02.010","volume":"28","author":"Writing Committee Members; ACC\/AHA Joint Committee Members","year":"2022","unstructured":"Writing Committee Members; ACC\/AHA Joint Committee Members. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure. J Card Fail. 2022;28(5):e1\u2013167.","journal-title":"J Card Fail"},{"key":"6004_CR3","doi-asserted-by":"publisher","first-page":"1335551","DOI":"10.3389\/fmed.2024.1335551","volume":"11","author":"S Dong","year":"2024","unstructured":"Dong S, Li D, Shi D. Skin barrier-inflammatory pathway is a driver of the psoriasis-atopic dermatitis transition. Front Med (Lausanne). 2024;11:1335551.","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"6004_CR4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.26444\/aaem\/112107","volume":"27","author":"M Roszkiewicz","year":"2020","unstructured":"Roszkiewicz M, Dopytalska K, Szyma\u0144ska E, et al. Environmental risk factors and epigenetic alternations in psoriasis. Ann Agric Environ Med. 2020;27(3):335\u201342.","journal-title":"Ann Agric Environ Med"},{"issue":"5","key":"6004_CR5","first-page":"1737","volume":"77","author":"S Ali Abd","year":"2022","unstructured":"Ali Abd S, Alsaffar JMJ, Agop AK, et al. Comparison of skin bacteria between psoriasis patients and healthy control. Arch Razi Inst. 2022;77(5):1737\u201340.","journal-title":"Arch Razi Inst"},{"issue":"6","key":"6004_CR6","first-page":"565","volume":"47","author":"B Xu","year":"2025","unstructured":"Xu B, Zhang X, Zhang C, et al. Dupilumab-Induced Immune Drift Phenomena in Atopic Dermatitis: Novel Insights into Mechanisms and Therapeutic Strategies. J Clin Pract Res. 2025;47(6):565\u201372.","journal-title":"J Clin Pract Res"},{"key":"6004_CR7","first-page":"32","volume":"3","author":"GK Kim","year":"2010","unstructured":"Kim GK, Del Rosso JQ. Drug-provoked psoriasis: is it drug induced or drug aggravated? Understanding pathophysiology and clinical relevance. J Clin Aesthet Dermatol. 2010;3:32\u20138.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"06","key":"6004_CR8","first-page":"523","volume":"57","author":"Chinese Neurology Society, Chinese Neurology Society Cerebrovascular Disease Group","year":"2024","unstructured":"Chinese Neurology Society, Chinese Neurology Society Cerebrovascular Disease Group. Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2023. Chin J Neurol. 2024;57(06):523\u201359.","journal-title":"Chin J Neurol"},{"issue":"15","key":"6004_CR9","first-page":"4215","volume":"48","author":"SX Peng","year":"2023","unstructured":"Peng SX, Wei C, Lei JY, et al. Network Meta-analysis of Chinese medicine injections for activating blood and resolving stasis in adjuvant treatment of acute ischemic stroke. Zhongguo Zhong Yao Za Zhi. 2023;48(15):4215\u201330.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"8","key":"6004_CR10","first-page":"901","volume":"20","author":"Chinese Society of Traditional Chinese Medicine Brain Disease Branch, Guangdong Society of Traditional Chinese Medicine Brain Disease Specialized Committee, Guangdong Society of Integrative Medicine Stroke Specialized Committee","year":"2020","unstructured":"Chinese Society of Traditional Chinese Medicine Brain Disease Branch, Guangdong Society of Traditional Chinese Medicine Brain Disease Specialized Committee, Guangdong Society of Integrative Medicine Stroke Specialized Committee. Evidence-based practice guideline on integrative medicine for stroke 2019. Chin J Evid Based Med. 2020;20(8):901\u201312.","journal-title":"Chin J Evid Based Med"},{"issue":"2","key":"6004_CR11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s12016-024-08991-7","volume":"66","author":"I Sieminska","year":"2024","unstructured":"Sieminska I, Pieniawska M, Grzywa TM. The Immunology of Psoriasis-Current Concepts in Pathogenesis. Clin Rev Allergy Immunol. 2024;66(2):164\u201391.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"9","key":"6004_CR12","doi-asserted-by":"publisher","first-page":"e15174","DOI":"10.1111\/exd.15174","volume":"33","author":"M Mori","year":"2024","unstructured":"Mori M, Kawakami H, Tobita R, et al. Psoriasiform drug eruption: A case series with a review of the literature. Exp Dermatol. 2024;33(9):e15174.","journal-title":"Exp Dermatol"},{"key":"6004_CR13","first-page":"87","volume":"7","author":"DM Balak","year":"2017","unstructured":"Balak DM, Hajdarbegovic E. Drug-induced psoriasis: clinical perspectives. Psoriasis (Auckl). 2017;7:87\u201394.","journal-title":"Psoriasis (Auckl)"},{"issue":"4","key":"6004_CR14","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s11096-018-0694-9","volume":"40","author":"SK Behera","year":"2018","unstructured":"Behera SK, Das S, Xavier AS, et al. Comparison of different methods for causality assessment of adverse drug reactions. Int J Clin Pharm. 2018;40(4):903\u201310.","journal-title":"Int J Clin Pharm"},{"issue":"5","key":"6004_CR15","first-page":"e59975","volume":"16","author":"PK Manjhi","year":"2024","unstructured":"Manjhi PK, Singh MP, Kumar M, Causality. Severity, Preventability and Predictability Assessments Scales for Adverse Drug Reactions: A Review. Cureus. 2024;16(5):e59975.","journal-title":"Cureus"},{"issue":"10","key":"6004_CR16","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/j.1552-4604.1992.tb04635.x","volume":"32","author":"CA Naranjo","year":"1992","unstructured":"Naranjo CA, Shear NH, Lanctot KL, et al. Advances in the diagnosis of adverse drug reactions. J Clin Pharmacol. 1992;32(10):897\u2013904.","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"6004_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.5021\/ad.2018.30.3.265","volume":"30","author":"SE Lee","year":"2018","unstructured":"Lee SE, Lee SH. Skin Barrier and Calcium. Ann Dermatol. 2018;30(3):265\u201375.","journal-title":"Ann Dermatol"},{"issue":"1","key":"6004_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.therap.2020.05.013","volume":"76","author":"B Azzouz","year":"2021","unstructured":"Azzouz B, Laugier-Castellan D, Sanchez-Pena P, et al. Calcium channel blocker exposure and psoriasis risk: Pharmacovigilance investigation and literature data. Therapie. 2021;76(1):5\u201311.","journal-title":"Therapie"},{"issue":"9","key":"6004_CR19","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1080\/14740338.2018.1508446","volume":"17","author":"B Azzouz","year":"2018","unstructured":"Azzouz B, Abou Taam M, Morel A, et al. Psoriasis during angiotensin receptor blocker exposure: an underestimated adverse drug reaction. Expert Opin Drug Saf. 2018;17(9):853\u20137.","journal-title":"Expert Opin Drug Saf"},{"issue":"9","key":"6004_CR20","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/exd.14159","volume":"29","author":"IMS Silva","year":"2020","unstructured":"Silva IMS, Assersen KB, Willadsen NN, Jepsen J, Artuc M, Steckelings UM. The role of the renin-angiotensin system in skin physiology and pathophysiology. Exp Dermatol. 2020;29(9):891\u2013901.","journal-title":"Exp Dermatol"},{"issue":"1","key":"6004_CR21","doi-asserted-by":"publisher","first-page":"10037","DOI":"10.1038\/s41598-021-89490-z","volume":"11","author":"G Song","year":"2021","unstructured":"Song G, Kim JY, Yoon HY, et al. A systematic review and meta-analysis of angiotensin-converting enzyme inhibitor use and psoriasis incidence. Sci Rep. 2021;11(1):10037.","journal-title":"Sci Rep"},{"key":"6004_CR22","first-page":"2627","volume":"120","author":"M Tanhapour","year":"2019","unstructured":"Tanhapour M, Falahi B, Vaisi-Raygani A, et al. Angiotensin-converting enzyme insertion\/deletion (rs106180) and angiotensin type 1 receptor A1166 C (rs106165) genotypes and psoriasis: Correlation with cellular immunity, lipid profile, and oxidative stress markers. J Cell Bio-chem. 2019;120:2627\u201333.","journal-title":"J Cell Bio-chem"},{"issue":"36","key":"6004_CR23","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599\u2013726.","journal-title":"Eur Heart J"},{"issue":"10","key":"6004_CR24","first-page":"e29809","volume":"14","author":"D Voloshyna","year":"2022","unstructured":"Voloshyna D, Ehsan Ullah S, Jahan N, et al. Beta-Blocker-Induced Erythrodermic Psoriasis: A Case Report. Cureus. 2022;14(10):e29809.","journal-title":"Cureus"},{"key":"6004_CR25","doi-asserted-by":"publisher","first-page":"2050313X2412840","DOI":"10.1177\/2050313X241284003","volume":"12","author":"SA Qureshi","year":"2024","unstructured":"Qureshi SA, Finch SE, Pratt ME. A case of probable drug-induced psoriasis to dapagliflozin. SAGE Open Med Case Rep. 2024;12:2050313X241284003.","journal-title":"SAGE Open Med Case Rep"},{"issue":"8","key":"6004_CR26","doi-asserted-by":"publisher","first-page":"e15603","DOI":"10.1111\/dth.15603","volume":"35","author":"AM Ibrahim","year":"2022","unstructured":"Ibrahim AM, Attwa EM, Benjuma HH. The exacerbating effect of atorvastatin on psoriasis. Dermatol Ther. 2022;35(8):e15603.","journal-title":"Dermatol Ther"},{"issue":"6","key":"6004_CR27","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.3390\/ijms27062603","volume":"27","author":"VM Mitrokhin","year":"2026","unstructured":"Mitrokhin VM, Kamkin AG, Babkina II, et al. Heart-Brain Axis in Viral Myocarditis: Shared Cytokine Pathways, Blood-Brain Barrier Crosstalk, and Neuroinflammatory Consequences. Int J Mol Sci. 2026;27(6):2603.","journal-title":"Int J Mol Sci"},{"issue":"14","key":"6004_CR28","doi-asserted-by":"publisher","first-page":"7499","DOI":"10.3390\/ijms23147499","volume":"23","author":"G Barros","year":"2022","unstructured":"Barros G, Duran P, Vera I, et al. Exploring the Links between Obesity and Psoriasis: A Comprehensive Review. Int J Mol Sci. 2022;23(14):7499.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"6004_CR29","first-page":"1351","volume":"11","author":"T Tokudome","year":"2022","unstructured":"Tokudome T, Otani K. Molecular Mechanism of Blood Pressure Regulation through the Atrial Natriuretic Peptide. Biology (Basel). 2022;11(9):1351.","journal-title":"Biology (Basel)"},{"issue":"22","key":"6004_CR30","doi-asserted-by":"publisher","first-page":"14415","DOI":"10.3390\/ijms232214415","volume":"23","author":"R Sarzani","year":"2022","unstructured":"Sarzani R, Allevi M, Di Pentima C, et al. Role of cardiac natriuretic peptides in heart structure and function. Int J Mol Sci. 2022;23(22):14415.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"6004_CR31","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1517\/13543784.2013.797962","volume":"22","author":"J Segura","year":"2013","unstructured":"Segura J, Salazar J, Ruilope LM. Dual neurohormonal intervention in CV disease: angiotensin receptor and Neprilysin inhibition. Expert Opin Investig Drugs. 2013;22(7):915\u201325.","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"6004_CR32","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3390\/cells10030650","volume":"10","author":"B Saravi","year":"2021","unstructured":"Saravi B, Li Z, Lang CN, et al. The Tissue Renin-Angiotensin Sys\u2043 tem and Its Role in the Pathogenesis of Major Human Diseases: Quo Vadis? Cells. 2021;10(3):650.","journal-title":"Cells"},{"issue":"4","key":"6004_CR33","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s10787-022-00962-8","volume":"30","author":"A Vitiello","year":"2022","unstructured":"Vitiello A, La Porta R, Trama U, et al. Pleiotropic effects of AT-1 receptor antagonists in hypoxia induced by cardiac ischaemia. Inflammopharmacology. 2022;30(4):1407\u201310.","journal-title":"Inflammopharmacology"},{"issue":"1","key":"6004_CR34","first-page":"1","volume":"5","author":"Chinese Society of Cardiology, Chinese College of Cardiovascular Physicians, Chinese Heart Failure Association of Chinese Medical Doctor Association","year":"2025","unstructured":"Chinese Society of Cardiology, Chinese College of Cardiovascular Physicians, Chinese Heart Failure Association of Chinese Medical Doctor Association. Chinese Guidelines for the Diagnosis and Treatment of Heart Failure 2024. Cardiol Discov. 2025;5(1):1\u201338.","journal-title":"Cardiol Discov"},{"key":"6004_CR35","doi-asserted-by":"crossref","unstructured":".Jallorina A, Vij K, Wan L, et al. A Decadal Exploration of Cutaneous Adverse Effects of FDA-Approved Cardiovascular Medications: Insights From 2013 to 2023. J Cardiovasc Pharmacol. 2025;85(2):97\u2013107.","DOI":"10.1097\/FJC.0000000000001660"},{"issue":"3","key":"6004_CR36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000092457","volume":"103","author":"C Maric","year":"2006","unstructured":"Maric C, Zheng W, Walther T. Interactions between angiotensin \u2161 and atrial natriuretic peptide in renomedullary interstitial cells: the role of neutral endopeptidase. Nephron Physiol. 2006;103(3):149\u201356.","journal-title":"Nephron Physiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06004-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06004-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06004-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T23:30:01Z","timestamp":1784503801000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06004-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6004"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06004-3","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"23 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patient has provided informed consent for publication of the case.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"611"}}